Below are the most recent publications written about "Interleukin-10" by people in Profiles.
-
Deshpande C, Khanduja S, Rondthaler SN, Andrews LB, Forbes NS. Suppression of Salmonella Effectors with CRISPRi Controls the Immune Response to Bacterial Therapies. ACS Synth Biol. 2026 Jul 17; 15(7):2912-2924.
-
Nishimi K, Linnstaedt SD, Neylan TC, McKibben LA, Albertorio-S?ez LM, Zhao Y, House SL, Beaudoin FL, An X, Stevens JS, Clifford GD, Jovanovic T, Germine LT, Rauch SL, Haran JP, Storrow AB, Musey PI, Hendry PL, Sheikh S, Punches BE, Swor RA, Pascual JL, Seamon MJ, Datner EM, Pearson C, Peak DA, Merchant RC, Domeier RM, Rathlev NK, O'Neil BJ, Sergot P, Sanchez LD, Bruce SE, Harte SE, Kessler RC, Koenen KC, Ressler KJ, McLean SA, O'Donovan A. Inflammatory markers in the emergency department and PTSD symptoms in the AURORA Study: A longitudinal cohort study. Psychol Med. 2026 May 08; 56:e123.
-
Dos Santos NSA, de Almeida-J?nior CR, Ricci MF, Sanches RCO, Fernandes RS, Burle-Caldas GA, de Castro JT, Reis-Cunha JL, Bartholomeu DC, Meira ACM, Nascimento TG, Oliveira NFM, Gazzinelli RT, Machado FS, Teixeira SMR. RNA and protein immunization with Trypanosoma cruzi trans-sialidase containing SAPA repeats protects mice against infection and promotes a balanced inflammatory response. Front Cell Infect Microbiol. 2025; 15:1681807.
-
de Souza Silva L, Monks BG, Forconi CS, Crabtree JN, De Paula Tamburro N, Kurt-Jones EA, Gazzinelli RT, Fitzgerald KA, Golenbock DT. Interleukin-10 limits immune-mediated pathology in chronic subclinical plasmodial infection. PLoS Negl Trop Dis. 2025 Sep; 19(9):e0013554.
-
Wang W, Wang Y, Sanidad KZ, Wang Y, Zhang J, Yang W, Sun Q, Bayram I, Song R, Yang H, Johnson D, Sherman HL, Kim D, Minter LM, Wong JJ, Zeng MY, Decker EA, Zhang G. Oxidized Polyunsaturated Fatty Acid Promotes Colitis and Colitis-Associated Tumorigenesis in Mice. J Crohns Colitis. 2025 Mar 05; 19(3).
-
Krajewski D, Ranjitkar S, Jordan N, Schneider SS, Mathias CB. IL-33 signaling is dispensable for the IL-10-induced enhancement of mast cell responses during food allergy. Front Immunol. 2025; 16:1526498.
-
Wang W, Dernst A, Martin B, Lorenzi L, Cadefau-Fabregat M, Phulphagar K, Wagener A, Budden C, Stair N, Wagner T, F?rber H, Jaensch A, Stahl R, Duthie F, Schmidt SV, Coll RC, Meissner F, Cuartero S, Latz E, Mangan MSJ. Butyrate and propionate are microbial danger signals that activate the NLRP3 inflammasome in human macrophages upon TLR stimulation. Cell Rep. 2024 09 24; 43(9):114736.
-
Krajewski D, Ranjitkar S, Tedeschi C, Perez NM, Jordan N, Mire M, Schneider SS, Mathias CB. IL-10 Neutralization Attenuates Mast Cell Responses in a Murine Model of Experimental Food Allergy. Immunohorizons. 2024 06 01; 8(6):431-441.
-
Ranjitkar S, Krajewski D, Garcia C, Tedeschi C, Polukort SH, Rovatti J, Mire M, Blesso CN, Jellison E, Schneider SS, Ryan JJ, Mathias CB. IL-10 Differentially Promotes Mast Cell Responsiveness to IL-33, Resulting in Enhancement of Type 2 Inflammation and Suppression of Neutrophilia. J Immunol. 2024 05 01; 212(9):1407-1419.
-
Dekamin S, Ghasemi M, Dehpour AR, Ghazi-Khansari M, Shafaroodi H. Protective Effects of Glatiramer Acetate Against Paclitaxel-Induced Peripheral Neuropathy in Rats: A Role for Inflammatory Cytokines and Oxidative Stress. Neurochem Res. 2024 Apr; 49(4):1049-1060.